Clinical trial
8-Week Atopic Dermatitis (AD) Treatment Study
NCT03386032 is registered in ClinicalTrials.gov with Procter and Gamble as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 8-Week Atopic Dermatitis (AD) Treatment Study
- Lead sponsor
- Procter and Gamble
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 27, 2017
- Completion date
- August 18, 2018
- Enrollment
- 65 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
atopic dermatitis eczema